Pay in 4 interest-free payments of $50.00 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
marketed for therapeutic use as Intron-A®
aa length 5) from the N-terminal region of Herpes Simplex Virus type-1 glycoprotein B
Fmoc-Asn(beta-D-Glc)-OH (Peracetate)
6 / A β-D-N-acetylgalactosamine (GalNAcβ) ligand equipped with an amine-functionalized linker through a hexyl spacer
AG523000: β-D-Glc-Ethyl-Amine Pack Size:50 mg marketed for therapeutic use asC8H17NO6 223. 22 A D glucose ligand equipped with an amine functionalized linker through a short ethyl spacer. The primary amine can be covalently coupled with N hydroxysuccinimide (NHS) activated esters to form stable amide bonds, providing a straightforward route to conjugate the ligand onto NHS activated molecules and surfaces. This compound provides a D glucose building block for glycoconjugate synthesis, glycomimetic research, and the
US$ 124.50
US$ 192.50
US$ 118.80
US$ 190.30
US$ 15.00
US$ 124.50
US$ 435.50
US$ 132.00
US$ 20.00
US$ 122.10
US$ 112.75
US$ 191.50
US$ 397.00
US$ 597.00
US$ 12.00
US$ 171.50
